Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety & Feasibility of Sodium Oxybate in Mild Alzheimer's Disease
NCT00706186Phase 4Terminated
- Sponsor
- Clayton Sleep Institute
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sodium oxybate in Alzheimer's disease (AD), sponsored by Clayton Sleep Institute. Status: terminated.
02
Drugs
sodium oxybate
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00706186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00706186.